Ausgabe 3/2017
Inhalt (19 Artikel)
Current status in cancer cell reprogramming and its clinical implications
Kenan Izgi, Halit Canatan, Banu Iskender
HOXB8 promotes tumor metastasis and the epithelial–mesenchymal transition via ZEB2 targets in gastric cancer
Wen-Jin Ding, Min Zhou, Mei-Mei Chen, Chun-Ying Qu
A specific mode of microsatellite instability is a crucial biomarker in adult T-cell leukaemia/lymphoma patients
Kaname Miyashita, Kei Fujii, Kenichi Taguchi, Mototsugu Shimokawa, Mitsuaki A. Yoshida, Yasunobu Abe, Jun Okamura, Shinya Oda, Naokuni Uike
Risk factors for intestinal metaplasia in a southeastern Chinese population: an analysis of 28,745 cases
Jian-Xia Jiang, Qing Liu, Bing Zhao, Hai-Han Zhang, Huai-Ming Sang, Soyfoo-Muhammad Djaleel, Guo-Xin Zhang, Shun-Fu Xu
53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM–CHK2–P53 pathway
Jing Yao, Ai Huang, Xiumei Zheng, Tao Liu, Zhenyu Lin, Sheng Zhang, Qin Yang, Tao Zhang, Hong Ma
Expression of PIWIL3 in primary and metastatic melanoma
Thilo Gambichler, Christina Kohsik, Ann-Kathrin Höh, Kerstin Lang, Heiko U. Käfferlein, Thomas Brüning, Eggert Stockfleth, Markus Stücker, Max Dreißigacker, Michael Sand
Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma
Thomas M. Atkinson, Jennifer L. Hay, Alexander Shoushtari, Yuelin Li, Daniel J. Paucar, Sloane C. Smith, Ragini R. Kudchadkar, Austin Doyle, Jeffrey A. Sosman, Jorge Fernando Quevedo, Mohammed M. Milhem, Anthony M. Joshua, Gerald P. Linette, Thomas F. Gajewski, Jose Lutzky, David H. Lawson, Christopher D. Lao, Patrick J. Flynn, Mark R. Albertini, Takami Sato, Karl Lewis, Brian Marr, David H. Abramson, Mark Andrew Dickson, Gary K. Schwartz, Richard D. Carvajal
BRAF V600E-dependent role of autophagy in uveal melanoma
Yinu Zhao, Weibin Wang, Irene Min, Brian Wyrwas, Maureen Moore, Rasa Zarnegar, Thomas J. Fahey III
Detection of vertebral metastases: a meta-analysis comparing MRI, CT, PET, BS and BS with SPECT
Tao Liu, Shenghao Wang, Hao Liu, Bin Meng, Feng Zhou, Fan He, Xiaojian Shi, Huilin Yang
Therapeutic role of axillary lymph node dissection in patients with stage IV breast cancer: a population-based analysis
San-Gang Wu, Feng-Yan Li, Yue Chen, Jia-Yuan Sun, Huan-Xin Lin, Qin Lin, Zhen-Yu He
Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99m with blue dye versus indocyanine green fluorescent dye
Andrea Papadia, Ignacio Zapardiel, Beatrice Bussi, Fabio Ghezzi, Marcello Ceccaroni, Elena De Ponti, Federica Elisei, Sara Imboden, Begoña Diaz de la Noval, Maria Luisa Gasparri, Giampaolo Di Martino, Javier De Santiago, Michael Mueller, Francesca Vecchione, Federica Dell’Orto, Alessandro Buda
Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results
Zhongzhi Jia, Ricardo Paz-Fumagalli, Gregory Frey, David M. Sella, J. Mark McKinney, Weiping Wang
FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?
Andrea Papadia, Maria Luisa Gasparri, Franziska Siegenthaler, Sara Imboden, Stefan Mohr, Michael D. Mueller
Presence of sarcomatoid differentiation as a prognostic indicator for survival in surgically treated metastatic renal cell carcinoma
Liangyou Gu, Hongzhao Li, Hanfeng Wang, Xin Ma, Lei Wang, Luyao Chen, Wenlei Zhao, Yu Zhang, Xu Zhang
Survival of de novo stage IV breast cancer patients over three decades
Dieter Hölzel, Renate Eckel, Ingo Bauerfeind, Bernd Baier, Thomas Beck, Michael Braun, Johannes Ettl, Ulrich Hamann, Nadia Harbeck, Marion Kiechle, Sven Mahner, Christian Schindlbeck, Johann de Waal, Jutta Engel
Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients’ prognosis
Theodoros Tokas, Margaritis Avgeris, Christos Alamanis, Andreas Scorilas, Konstantinos G. Stravodimos, Constantinos A. Constantinides
Improvement of overall survival in stage IV melanoma patients during 2011–2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR)
Andrea Forschner, Felizitas Eichner, Teresa Amaral, Ulrike Keim, Claus Garbe, Thomas Kurt Eigentler
A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO)
Jalid Sehouli, Oliver Tomè, Desislava Dimitrova, Oumar Camara, Ingo Bernhard Runnebaum, Hans Werner Tessen, Beate Rautenberg, Radoslav Chekerov, Mustafa Zelal Muallem, Michael Patrick Lux, Tanja Trarbach, Gerald Gitsch
Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer
Isao Oze, Shu Shimada, Hiromi Nagasaki, Yoshimitsu Akiyama, Miki Watanabe, Yasushi Yatabe, Keitaro Matsuo, Yasuhito Yuasa